Strosberg, J. (2018). (177)Lutetium-Dotatate delays decline in quality of life in patients with midgut neuroendocrine tumors. Oncotarget.
Chicago Style CitationStrosberg, Jonathan. "(177)Lutetium-Dotatate Delays Decline in Quality of Life in Patients With Midgut Neuroendocrine Tumors." Oncotarget 2018.
Cita MLAStrosberg, Jonathan. "(177)Lutetium-Dotatate Delays Decline in Quality of Life in Patients With Midgut Neuroendocrine Tumors." Oncotarget 2018.
Atenció: Aquestes cites poden no estar 100% correctes.